Login / Signup
Cost-effectiveness of Tocilizumab in Severe Coronavirus Disease 2019: to See or Not to See.
Lauren Pischel
George Goshua
Published in:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Keyphrases
</>
coronavirus disease
rheumatoid arthritis
juvenile idiopathic arthritis
early onset
rheumatoid arthritis patients
respiratory syndrome coronavirus